Opendata, web and dolomites
H2020 projects about "metastasis"
The page lists 136 projects related to the topic "metastasis".
| # | |||
|---|---|---|---|
| 1 | MULTIMOT | Capture, dissemination and analysis of multiscale cell migration data for biological and clinical applications (MULTIMOT) | 2015 |
| 2 | INTRAHETEROSEQ | Molecular characterization of the role of intra-tumor heterogeneity in cancer progression and metastasis | 2015 |
| 3 | Medulloblastoma | Molecularly defined models of human childhood brain tumors | 2015 |
| 4 | NDI | Nano-diamond tracers for MRI molecular imaging | 2014 |
| 5 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 6 | BALaNCE | BreAking the Link betweeN myo10 and CancEr | 2015 |
| 7 | ONCORNET | ONCOgenic Receptor Network of Excellence and Training | 2015 |
| 8 | BonePain | European Training Network on Bone Pain | 2015 |
| 9 | GLYCANC | Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer | 2015 |
| 10 | LYMPHORG | Organ-specific mechanisms of lymphatic vascular development and specialisation | 2015 |
| 11 | Brain Metastases | The Role of Circulating Monocytes in the Development of Brain Metastases | 2015 |
| 12 | miROMeS | miRNA biomarkers of Osseous Metastases in Serum from breast cancer patients | 2015 |
| 13 | Cdc42Adhere | Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets | 2015 |
| 14 | HspAdhesion | Role of cell membrane associated Hsp70 in cancer cell adhesion and metastasis | 2015 |
| 15 | WORMTUMORS | Worm power: Can helminths modify the development of colorectal cancer? | 2015 |
| 16 | breast cancer dormancy | Molecular characterisation of a clinical model of estrogen receptor-positive breast cancer dormancy | 2015 |
| 17 | GENMETASTEM | GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS | 2016 |
| 18 | MACROIMAGING | Specific Fluorogenic Peptides for Imaging Metastasis-associated Macrophages | 2015 |
| 19 | CICCI | Characterization of Intestinal Cancer Cell Invasion | 2015 |
| 20 | FiBRO | Fibroblasts in the Biology of Rectal Cancer Progression | 2016 |
| 21 | ACM | Cholesterol metabolism as a driver of prostate cancer aggressiveness | 2015 |
| 22 | S-OS | Exosomes as microenvironmental cue for engaging mesenchymal stem cells in osteosarcoma progression | 2016 |
| 23 | MyNano | Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients | 2015 |
| 24 | MEDICIS-PROMED | MEDICIS-produced radioisotope beams for medicine | 2015 |
| 25 | NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages | 2015 |
| 26 | CAPTURE-CTC | A Streptavidin Microarray Platform for Capturing of Circulating Tumor Cells from the Blood of Cancer Patients | 2015 |
| 27 | CSC-IS | Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system. | 2015 |
| 28 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
| 29 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 30 | Cancer-Recurrence | Tumor cell death supports recurrence of cancer | 2015 |
| 31 | COMbAT | Commercialization of a novel tool for designing personalized nOvel MelAnoma Therapies | 2015 |
| 32 | Bcl-Inhib | Discovery of Bcl-3 inhibitors as Potential Chemopreventive Agent for skin cancer | 2015 |
| 33 | ReTuBi | Towards outstanding research and training in tumour biology at IMM | 2016 |
| 34 | BD2Decide | Big Data and models for personalized Head and Neck Cancer Decision support | 2016 |
| 35 | OptiQ-CanDo | Hybrid Optical Interferometry for Quantitative Cancer Cell Diagnosis | 2016 |
| 36 | HOLDING-HANDS | Holding hands: cell-cell junctions in breast cancer metastasis and resistance to therapy | 2016 |
| 37 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 38 | MOMENDO | Molecular Mechanisms of Endometriosis | 2016 |
| 39 | PDA_TGFb | TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis | 2017 |
| 40 | MIRNANO | Multifunctional miRNA-targeting nanodevices for pluripotent cancer theranostics | 2017 |
| 41 | INTO | Inorganic therapeutic nanoparticles for osteoporosis | 2016 |
| 42 | RAMSES | Aryl amide metallofoldamersas selective saccharide sensors | 2016 |
| 43 | PERICYTEStroma | Pericyte-derived tumor stroma – a target for cancer therapy | 2016 |
| 44 | NIR-BIO-FLU | Bio-conjugatable and Bio-responsive Near Infrared Fluorochromes | 2016 |
| 45 | RAC | Defining the Role of Antioxidants on Cancer progression and metastasis | 2016 |
| 46 | HeteroCancerInvasion | Effect of heterogeneity of cancer cells on collective invasion | 2016 |
| 47 | EC GNG metabolism | Endothelial Gluconeogenesis: a novel target for tumor anti-angiogenesis? | 2017 |
| 48 | OSTEOMET | Clinical Validation of a Novel Biomarker for the Prediction of Bone Metastasis in Early Stage Breast and Prostate Cancer | 2016 |
| 49 | MRCKa in cancer | Targeting Cancer Cell Invasion and Metastasis by Inhibition of the Serine Kinase MRCKa | 2016 |
| 50 | FLUORODRUGS | Smart Theranostic Agents for the Tumour Microenvironment | 2017 |
| 51 | DLL4-LVN | Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma | 2017 |
| 52 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 53 | STEM-BCPC | Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer | 2016 |
| 54 | PLEIO-RANK | Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity | 2016 |
| 55 | TNT-TUMORS | Therapeutic approaches to enhance innate immunity against Tumors | 2016 |
| 56 | MATRICAN | Matrix during cancer progression | 2016 |
| 57 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 58 | HypoSens | Nano-confined photonic system for detection of breast cancer spread to the lymph nodes | 2016 |
| 59 | McHAP | Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP | 2017 |
| 60 | SCUBA CANCERS | Finding the genetic causes of contagious metastases under the sea | 2017 |
| 61 | SUPRACELL_COMMUN_CCT | Supracellular contractility dynamics and cell communication during collective chemotaxis. | 2016 |
| 62 | MetResistance | The role of tumour microenvironment in metastatic hormone-refractory prostate cancer | 2017 |
| 63 | MECHANICS | Mechanics of cells: the role of intermediate filaments | 2017 |
| 64 | BCSC-ST | Breast cancer stem-like cells specific vulnerabilities: focus in HER2 over-expression and protein glycosylation | 2017 |
| 65 | MSCFate | Fate of mammary stem cells during tumorigenesis and clinical implications | 2017 |
| 66 | MiRCHOL | Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer | 2017 |
| 67 | METMEL | Long range-acting drivers of premetastatic niches in melanoma | 2017 |
| 68 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 69 | META-DORM | Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions | 2018 |
| 70 | HoldCancerBack | What Holds Cancer Cells Back? | 2017 |
| 71 | STOPCa | The cryptic path of tumor-microenvironment interactions in prostate cancer | 2017 |
| 72 | ESEMT | DETERMINING THE FUNCTIONAL CONSEQUENCES OF TRANSCRIPTIONAL ENHANCER ACTIVATION ON ALTERNATIVE SPLICING DURING EMT | 2017 |
| 73 | NEOSETAC | New Selenium-based Targeted Nanocapsules to treat Breast Cancer | 2018 |
| 74 | bloodANDbone | Blood and bone – conjoined twins in health and disease: bone marrow analogs for hematological and musculoskeletal diseases | 2018 |
| 75 | GlycoEdit | New Chemical Tools for Precision Glycotherapy | 2017 |
| 76 | DualRP | Exploring cell interactions in the tumor microenvironment with dual ribosome profiling | 2018 |
| 77 | CTC-MAL | Isolation of rare circulating tumor cells | 2018 |
| 78 | NIRCOThera | Spatiotemporal, near-infrared light controlled carbon monoxide delivery for cancer immunotherapy | 2018 |
| 79 | DYNAFLUORS | Dynamic Activatable Fluorophores | 2018 |
| 80 | EMBRACE | Elucidating Mechanisms of Bladder Cancer Metastasis | 2018 |
| 81 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 82 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
| 83 | MELANCHOR | Understanding the Role of Motors in Subcellular Mechanics of Organelles by Controlling Myo6-Cargo Interactions in situ | 2018 |
| 84 | VulneraBAP1 | Mechanism and vulnerability of BAP1 loss in tumor metastasis | 2018 |
| 85 | UNNAMEd-2 | Unraveling the conceptional novel ADAM17 regulation by PP2A in metastasis formation. | 2019 |
| 86 | GDCOLCA | Understanding gamma delta T cells in colon cancer metastasis | 2018 |
| 87 | NICI | Non-Invasive Chemistry Imaging in the whole human body | 2018 |
| 88 | B2B | Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity. | 2018 |
| 89 | QuantOCancer | Leveraging the unique organismic approach to health and disease of the Champalimaud Foundation through the inception of a quantitative biomedicine research programme focused on cancer | 2018 |
| 90 | LIPOMET | Dietary Influences on Metastasis: How, When, and Why | 2018 |
| 91 | SelectiveTGFb-inhib | Pro-tumorigenic effects of TGFb - elucidation of mechanisms and development of selective inhibitors | 2018 |
| 92 | RV001 | RV001: An anti-metastatic cancer vaccine | 2018 |
| 93 | STARNEL | supracellular contractility of myofibroblasts in gut homeostasis and cancer invasion | 2018 |
| 94 | BonePainII | A European Training Network to Combat Bone Pain | 2019 |
| 95 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
| 96 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 97 | VeCare | Selective retention of VEGF for cancer and retinopathies therapeutics | 2019 |
| 98 | METANICHE | Regulation of bone metastases by age-associated angiocrine signals | 2019 |
| 99 | FRINGE | Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies | 2019 |
| 100 | FanCY | Flow and Deformation of Cancer tumours near Yielding | 2019 |
| 101 | PACA-MET | Genome-wide surveys and functional analysis of pancreatic cancer metastasis drivers | 2019 |
| 102 | Cluster-Buster | Development of small molecule inhibitors of circulating tumor cell clusters | 2019 |
| 103 | IntratumoralNiche | Defining heterocellular signalling within the intratumoral stem cell niche of colorectal cancer | 2019 |
| 104 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 105 | INHuMAN | Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma | 2019 |
| 106 | BrEXo-Apt | Non-invasive and accurate diagnosis and treatment of breast cancer. | 2019 |
| 107 | EVOMET | The rise and fall of metastatic clones under immune attack | 2019 |
| 108 | EndoPos | Endosome positioning in tumour-stroma interactions | 2019 |
| 109 | PB_dormancy | Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis | 2020 |
| 110 | MetaTarGet | Targeting metabolic regulation in metastasis formation | 2019 |
| 111 | MechTransition | Regulatory mechanisms controlling a new mechanical Epithelial to Mesenchymal Transition in zebrafish | 2020 |
| 112 | META2 | METAbolism of bone METAstasis (META2): Metabolic interactions between disseminated breast cancer cells and osteoblast lineage cells drive bone metastases formation | 2019 |
| 113 | ICE-METs | Interstitium-on-a-chip to explore its role in cancer metastasis | 2019 |
| 114 | Tumor microbiome | The tumor microbial communities: Characterization, effects and translational opportunities | 2019 |
| 115 | CancerADAPT | Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits | 2019 |
| 116 | MIRACLE | Metabolic Imaging with RF Antennas to predict Chemotherapy Efficacy | 2019 |
| 117 | Breakborder | Breaking borders, Functional genetic screens of structural regulatory DNA elements | 2019 |
| 118 | MS | Unravelling the molecular and cellular mechanism of metastasis | 2020 |
| 119 | INJURMET | Impact of tissue injury induced by diagnostic biopsies and surgery on cancer metastasis | 2019 |
| 120 | SECRET | Exploitation of the SECRETory pathway for cancer therapy to address European research | 2019 |
| 121 | 3DCanPredict | Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy | 2019 |
| 122 | RV001 | RV001: An anti-metastatic cancer vaccine | 2019 |
| 123 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 124 | ONco-Energetics_OFF | Dissection of Bioenergetic Plasticity of Tumors | 2020 |
| 125 | M6AQuantKit | Development and commercialization of kit for quantitative interrogation of a key RNA modification | 2020 |
| 126 | ALTER-brain | Metastasis-associated altered molecular patterns in the brain | 2020 |
| 127 | METABOLIGHT | Optical imaging platform to unravel metabolic reprogramming of cancer: a path for improved treatments | 2020 |
| 128 | Ru4EYE | Ruthenium-based photoactivated chemotherapy against eye cancer | 2020 |
| 129 | BRCAstem | Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells | 2020 |
| 130 | NetriCan | Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. | 2020 |
| 131 | StressRhomboid | Trapping intramembrane protease substrates in living cells: focus on RHBDL4 role in ERAD | 2020 |
| 132 | BESG | Bioengineered exosomes based approaches for the effective treatment of non-small cell lung cancer | 2020 |
| 133 | BiCiCle | Biophysics of circulating tumor cells, from single molecule to cell clusters | 2020 |
| 134 | RMAG | Rheology and Mechanics of Active Glasses | 2021 |
| 135 | RabTarget4Metastasis | Targeting Rab27A with covalent inhibitors for the treatment of metastatic breast cancer | 2020 |
| 136 | MRTFSen | MRTF/SRF signalling in regulation of cell senescence and melanoma progression | 2020 |